Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
1
Price
$5.70
Total Value
$5.70
Shares Held After
1,856,988
% of Holdings
0.0%
Roivant Sciences Ltd. (ROIV)
Torti Frank — President and Vant Chair
Shares
1,012,610
Price
$27.15
Total Value
$27.49M
Shares Held After
13,736,547
% of Holdings
6.9%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
2
Price
$5.70
Total Value
$11.40
Shares Held After
1,856,989
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
5,576
Price
$5.71
Total Value
$31.86K
Shares Held After
1,856,991
% of Holdings
0.3%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
40,401
Price
$5.87
Total Value
$236.95K
Shares Held After
1,862,567
% of Holdings
2.1%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
309
Price
$5.71
Total Value
$1.77K
Shares Held After
262,912
% of Holdings
0.1%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
2,234
Price
$5.87
Total Value
$13.10K
Shares Held After
263,221
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Kelliher Mike — See Remarks
Shares
2
Price
$5.71
Total Value
$11.41
Shares Held After
364,666
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Williams Laura A — See Remarks
Shares
984
Price
$5.71
Total Value
$5.62K
Shares Held After
436,082
% of Holdings
0.2%
ARDELYX, INC. (ARDX)
Kelliher Mike — See Remarks
Shares
1,159
Price
$5.71
Total Value
$6.62K
Shares Held After
364,668
% of Holdings
0.3%
ARDELYX, INC. (ARDX)
Williams Laura A — See Remarks
Shares
7,192
Price
$5.87
Total Value
$42.18K
Shares Held After
437,066
% of Holdings
1.6%
ARDELYX, INC. (ARDX)
Kelliher Mike — See Remarks
Shares
8,434
Price
$5.87
Total Value
$49.47K
Shares Held After
365,827
% of Holdings
2.3%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
1
Price
$5.70
Total Value
$5.70
Shares Held After
425,970
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
1
Price
$5.71
Total Value
$5.71
Shares Held After
425,971
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
1,261
Price
$5.71
Total Value
$7.21K
Shares Held After
425,972
% of Holdings
0.3%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
9,176
Price
$5.87
Total Value
$53.82K
Shares Held After
427,233
% of Holdings
2.1%
ANI PHARMACEUTICALS INC (ANIP)
Mutz Christopher — HEAD OF RARE DISEASE
Shares
5,323
Price
$78.02
Total Value
$415.30K
Shares Held After
84,840
% of Holdings
5.9%
ANI PHARMACEUTICALS INC (ANIP)
Davis Krista — SVP, CHIEF HR OFFICER
Shares
1,730
Price
$77.99
Total Value
$134.92K
Shares Held After
49,263
% of Holdings
3.4%
JOHNSON & JOHNSON (JNJ)
Schmid Timothy — EVP, WW Chair, MedTech
Shares
1,322
Price
$245.66
Total Value
$324.76K
Shares Held After
25,447
% of Holdings
4.9%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
8,000
Price
$14.30
Total Value
$114.40K
Shares Held After
181,977
% of Holdings
4.2%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
3,742
Price
$13.62
Total Value
$50.97K
Shares Held After
181,977
% of Holdings
2.0%
Cullinan Therapeutics, Inc. (CGEM)
Jones Jeffrey Alan — Chief Medical Officer
Shares
4,982
Price
$13.62
Total Value
$67.85K
Shares Held After
164,550
% of Holdings
2.9%
Cullinan Therapeutics, Inc. (CGEM)
AHMED NADIM — Director
Shares
16,381
Price
$13.62
Total Value
$223.11K
Shares Held After
404,318
% of Holdings
3.9%
Cullinan Therapeutics, Inc. (CGEM)
Fenton Mary Kay — Chief Financial Officer
Shares
4,398
Price
$13.62
Total Value
$59.90K
Shares Held After
126,380
% of Holdings
3.4%
Cullinan Therapeutics, Inc. (CGEM)
SUMER JACQUELYN L — Chief Legal Officer
Shares
3,742
Price
$13.62
Total Value
$50.97K
Shares Held After
131,690
% of Holdings
2.8%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
397
Price
$51.96
Total Value
$20.63K
Shares Held After
22,600
% of Holdings
1.7%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,643
Price
$51.38
Total Value
$341.34K
Shares Held After
22,997
% of Holdings
22.4%
ACCURAY INC (ARAY)
MAYER STEVEN F — Director
Shares
54,875
Price
$0.56
Total Value
$30.88K
Shares Held After
1,545,620
% of Holdings
3.6%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
100,000
Price
$1.48
Total Value
$147.79K
Shares Held After
1,804,186
% of Holdings
5.5%
INSULET CORP (PODD)
McEvoy Ashley — Director
Shares
4,300
Price
$239.35
Total Value
$1.03M
Shares Held After
13,916
% of Holdings
30.9%
RAPID MICRO BIOSYSTEMS, INC. (RPID)
WIRTJES SEAN M — CHIEF FINANCIAL OFFICER
Shares
17,254
Price
$3.92
Total Value
$67.69K
Shares Held After
563,674
% of Holdings
3.0%
RAPID MICRO BIOSYSTEMS, INC. (RPID)
Wilson John J. Addington — CHIEF OPERATING OFFICER
Shares
5,403
Price
$3.92
Total Value
$21.20K
Shares Held After
326,365
% of Holdings
1.6%
Tempus AI, Inc. (TEM)
Polovin Andrew — EVP, Chief Legal Officer
Shares
100
Price
$60.97
Total Value
$6.10K
Shares Held After
126,918
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
Polovin Andrew — EVP, Chief Legal Officer
Shares
10,849
Price
$60.30
Total Value
$654.19K
Shares Held After
127,018
% of Holdings
7.9%
ENSIGN GROUP, INC (ENSG)
Uychiat Pison Marivic — Director
Shares
67
Price
$204.92
Total Value
$13.73K
Shares Held After
14,340
% of Holdings
0.5%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
9,920
Price
$17.86
Total Value
$177.17K
Shares Held After
25,000
% of Holdings
39.7%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
600
Price
$88.10
Total Value
$52.86K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
1,900
Price
$87.06
Total Value
$165.41K
Shares Held After
600
% of Holdings
76.0%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
13,587
Price
$59.05
Total Value
$802.31K
Shares Held After
1,989,626
% of Holdings
0.7%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
3,716
Price
$59.70
Total Value
$221.85K
Shares Held After
15,922,469
% of Holdings
0.0%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
95,567
Price
$59.04
Total Value
$5.64M
Shares Held After
15,926,185
% of Holdings
0.6%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
33,717
Price
$58.31
Total Value
$1.97M
Shares Held After
16,021,752
% of Holdings
0.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
923
Price
$59.70
Total Value
$55.10K
Shares Held After
8,908,283
% of Holdings
0.0%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
23,775
Price
$59.04
Total Value
$1.40M
Shares Held After
8,909,206
% of Holdings
0.3%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
8,552
Price
$58.31
Total Value
$498.67K
Shares Held After
8,932,981
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
Torti Frank — President and Vant Chair
Shares
1,400,000
Price
$27.42
Total Value
$38.39M
Shares Held After
13,736,547
% of Holdings
9.2%
Avantor, Inc. (AVTR)
LUCIER GREGORY T — Director
Shares
50,000
Price
$9.16
Total Value
$458.00K
Shares Held After
50,000
% of Holdings
100.0%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
10,834
Price
$262.10
Total Value
$2.84M
Shares Held After
78,691
% of Holdings
12.1%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
8,116
Price
$260.49
Total Value
$2.11M
Shares Held After
89,525
% of Holdings
8.3%
EXELIXIS, INC. (EXEL)
Aftab Dana — EVP, Research and Development
Shares
29,873
Price
$44.35
Total Value
$1.32M
Shares Held After
664,024
% of Holdings
4.3%
Showing 401–450 of 1586 transactions (page 9 of 32)